NUTX

Nutex Health Inc.

$186.25

-4.07%
SectorHealthcareIndustryMedical Care FacilitiesCountryUnited States

Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.

Source: Yahoo Finance
AI summary

Price & performance

1M-14.3%
3M+25.9%
YTD+25.2%
1Y+50.8%
52-week range—
Beta1.55
Full chart and returns against a benchmark

Q-Score

72/ 100

Quality against peers; 50 is the peer median.

Growth57
Risk39
Performance75
Valuation82
Profitability71
Leverage63
Sentiment71
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$875.3M+82.4%
Net income$70.8M+35.9%
Net margin8.1%-2.8 pts
Historical fundamentals

Red flags in filings

4active red flags
Restated financialsAug 21, 2025
Late filing noticeNov 17, 2025
Auditor changeMay 21, 2025
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Regions, segments, customers and suppliers

Valuation

NUTXIndustryP/E7.7612.66P/S1.601.15EV/EBITDA3.2113.41P/B2.937.42PEG0.210.49
Dividend yield0.00%
Every valuation metric

Earnings

Nov 5next report
EPS estimate—
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate